The Institute of Ocular Microcirgey (IMO) of Barcelona, one of the ophthalmological centers of worldwide reference in retinal diseases associated with diabetes, will be present on February 14 at the Experience Day 2015 diabetes that will be held in Valencia.
Through the IMO Foundation, a non -profit entity that promotes prevention, teaching and research activities in ophthalmology, institute specialists will carry out optometric and ophthalmological reviews to those attending the event who wish.The exam will include visual acuity tests, intraocular pressure taking, refraction control, biomicroscopy and exploration of the bottom of the eye in a cleft lamp, a diagnostic test that allows us to see possible injuries or retinal spills and that is basic in people with diabetes,A population group with 25 times more risk of severe loss of vision.
Diabetic retinopathy is the main complication of diabetes and the most frequent vascular disease of the retina, whose blood cells and vessels are damaged by the metabolic decompensation of diabetes.This derives neovascularization or spontaneous creation of new fragile vessels that lose blood (proliferative diabetic retinopathy), which can affect vision in a very important way.But the complication of the most devastating retinopathy for vision is the diabetic macular edema, which consists of a liquid accumulation in the macula or center of the retina, produced by the leaks of the damaged retinal vessels as a result of the diabetic retinopathy.These complications make diabetic retinopathy the cause of severe loss of vision most frequent in industrialized countries among the active population.
In spite of everything, the early and adequate treatment of the disease - by laser photocoagulation, intravitee injections or vitrectomy - avoids blindness in more than 90% of cases.Therefore, early diagnosis is key, since it allows acting when retinal damage is still incipient.Since diabetic retinopathy is usually asymptomatic in this phase, it is essential to submit to periodic revisions of the retina - minimal annually - such as the one that the IMO Foundation will perform in the Experience Day Diabetes.In addition, IMO specialists remember the importance of adopting other preventive measures to improve the prognosis of the disease or delay its appearance, among which are strict control of glycemia, blood pressure and plasma lipids, in addition toAvoid tobacco.
on the IMO
The IMO is an ophthalmological center of international reference, founded more than 25 years ago by Dr. Borja Corcóstegui, recently chosen as the ophthalmologist with the best reputation in Spain, according to the first sanitary reputation monitor (MRS), a recent study, whichClassify the best hospitals, hospital services and medical professionals for specialties, based on interviews with 2,400 doctors, nurses, patients and specialized journalists and in 186 objective indicators of quality and care performance.
Dr. Corcóstegui heads the IMO and vitreous department, which is also part of doctors José García-Arumí, Carlos Mateo, Rafael Navarro, Anniken Burés and Cecilia Salinas.The department has a diabetic retinopathy unit, especially dedicated to the care of the diabetic patient and associated complications, such as macular edema, vitreous hemorrhage and retinal detachment.In addition to offering highly specialized medical and surgical care for these patients, IMO ophthalmologists also actively participate in new treatments to improve the vision and quality of life of these patients.
The InstituteIt has a team of 180 people at the service of the patient and with facilities of 24,000 square meters, opened in 2009, where it has 70 medical consultations and eight operating rooms equipped with the latest technology in ophthalmological surgery without admission.
650,000 adults have been diagnosed with diabetes in New York Complication Oculardr.Borja Corcósteguifundacion Imoimoinstituto Microcirugía Ocularretinopathy diabetic.